Physician profile
Bernard Azer
NPI 1285686220
$1,007.32
in general payments reported to CMS, 2019-2025
5 companies · $461 in 2025
The $461 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.98 · 2020: $168 · 2021: $87.43 · 2022: $12.52 · 2023: $99.33 · 2024: $157 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.11 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $351.56 | 2025 | Ibsrela, Xphozah 30 Mg |
| Akebia Therapeutics INC | $280.39 | 2020-2025 | Vafseo, Auryxia |
| Vifor Pharma, INC. | $260.09 | 2019-2024 | Veltassa |
| Calliditas Therapeutics US INC. | $89.99 | 2024-2025 | Tarpeyo |
| Depuy Synthes Sales INC. | $25.29 | 2025 | Cerepak Uniform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Azer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.